JONBUR Research · Initiation

Hecto Innovation · 214180 · Internet

Hecto Innovation: Low Multiples and Net Cash Alongside a 22.6% One-Year Share Price Decline

Why this report

Start of coverage: written when a reader opened this company and there was no report yet.

Hecto Innovation (KOSDAQ, Internet) closed at ₩12,700 on 2026-10-27, down 22.6% over one year and close to its 52-week low of ₩12,210. Filed numbers show trailing revenue of ₩409.6B, a 12.8% operating margin and net cash, with a P/E of 6.4 and a P/B of 0.7.

Written Oct 28, 2026 · Data as of Oct 27, 2026 · 0 views

This is not financial advice. The report does not recommend buying or selling anything.

Thesis

The data supports a picture of a profitable, growing company priced at low multiples. Revenue has risen every year from ₩221.0B in 2021 to ₩375.8B in 2025, and trailing revenue to H1 2026 is ₩409.6B. Cash of ₩298.8B far exceeds borrowings of ₩10.0B, and enterprise value is negative at about -₩123.8B. The dividend yield is 3.9%.

What the data does not support is a clear explanation for the share price weakness. No news headlines are available, and the filings list shows no earnings surprise. Operating margin has eased from 17.0% in 2021 and 15.3% in 2024 to 12.8% on a trailing basis, and ROE has slipped from 14.9% in 2024 to 11.9%. Net income of ₩25.8B is below the ₩30.5B of 2025. The market may be pricing in slower profitability, but the data does not confirm this.

Business overview

Hecto Innovation is listed on the KOSDAQ and classified in the Internet sector. It was founded on 2009-03-19 and listed on 2015-06-30. It has 12,993,367 listed shares and a market capitalization of about ₩165.0B. That is far smaller than peers such as NAVER (₩26.5T) and Kakao (₩13.1T), and also smaller than Daou Technology (₩1.4T) and NICE Information Service (₩975.4B). The data gives no breakdown of products or business lines.

Financial analysis

These figures come from filed financial statements. Annual revenue grew 17.6% in 2025 to ₩375.8B, after growth of 10.7% in 2024, 9.7% in 2023 and 19.0% in 2022. Operating income was ₩50.2B in 2025 (13.4% margin), versus ₩48.9B in 2024 (15.3%). Net income was ₩30.5B in 2025 versus ₩27.9B in 2024. ROE was 14.2% in 2025 and 21.3% in 2022.

On a trailing basis to H1 2026, revenue is ₩409.6B, operating income ₩52.5B (12.8% margin) and net income ₩25.8B (6.3% margin). ROE is 11.9%. Liabilities to equity are 115%. Free cash flow is ₩64.5B, above net income. Cash is ₩298.8B against borrowings of ₩10.0B.

Valuation

The current P/E of 6.4 and P/B of 0.7 compare with year-end P/E readings of 5.3 to 12.4 and P/B of 0.8 to 1.9 over 2021 to 2025. The P/B is below every year-end reading shown. The P/S is 0.4. EV/EBITDA is not available. Among peers, P/E is 13.1 for NAVER, 37.7 for Kakao, 1.9 for Daou Technology, 11.3 for NICE Information Service and 24.4 for Kinx. P/B is 0.9, 1.1, 0.4, 2.0 and 2.7 respectively.

The valuation model, a 5-year discounted cash flow at a 7.4% rate based on trailing figures to H1 2026, gives a model estimate based on the assumptions shown of ₩98,746 per share in the base case, with ₩70,077 in the bear case and ₩145,612 in the bull case. All three are well above the ₩12,700 share price. This gap shows how sensitive such a model is to its assumptions, particularly given the large cash balance. It is not a target or a reason to buy or sell.

Catalysts

  • The half-year report for June 2026 was filed on 2026-08-14, and the amended preliminary earnings on 2026-08-07 give the latest read on trailing results.
  • The next quarterly earnings filings will show whether the 12.8% trailing operating margin stabilizes.
  • Repeated 5%+ holding reports (2026-04-16, 2026-04-30, 2026-06-18 and 2026-09-18) point to changes in major shareholder positions.
  • Over the last 20 days foreign investors were net buyers (₩551M) and institutions were small net buyers (₩89M), while retail investors were net sellers (₩297M).
  • An investor relations event was held on 2026-08-21, which may indicate company communication with the market.

Risks

  • Operating margin has declined from 17.0% in 2021 to 12.8% on a trailing basis, and ROE has fallen to 11.9%.
  • Net income of ₩25.8B on a trailing basis is below the 2025 level of ₩30.5B even as revenue grows.
  • The share price fell 9.5% in the past month and sits close to its 52-week low, showing negative momentum.
  • Small market capitalization (about ₩165.0B) on the KOSDAQ can mean lower liquidity and larger price swings.
  • No news headlines are available, so the reasons for the price decline cannot be assessed, and the model's wide range (₩70,077 to ₩145,612) reflects substantial uncertainty.

Closing view

The filed numbers show a growing, profitable company with a net cash position, a 3.9% dividend yield and multiples below both its own history and most listed peers. Against that, margins and returns have trended lower, trailing net income is down from 2025, and the share price has fallen 22.6% in a year. The model estimate is far above the market price, but it depends on assumptions and cannot explain why the market values the company so low. The evidence is mixed: the balance sheet and cash flow look solid, while the earnings trend and the price trend point in different directions.

Model estimate of fair value

Bear
₩70,077
+462%
Base
₩98,746
+692%
Bull
₩145,612
+1068%

Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.

Base case of the 5-year discounted cash flow model on the stock's Valuation tab (statements TTM to H1 2026; discount rate 7.4%). Bear and Bull move the main assumptions by fixed steps. See and change the assumptions

Filings and data used

Report history

  1. Oct 28, 2026InitiationStart of coverage (reader request)Hecto Innovation: Low Multiples and Net Cash Alongside a 22.6% One-Year Share Price Decline

Built only from jonbur's own data: prices and investor flows, filed financial statements and filings, and news headlines. Disclosed (filed) data is labelled as such. Written by AI and may contain mistakes.

This is not financial advice. The report does not recommend buying or selling anything.

Source: KRX statistical information